Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's Disease

Clinical trial NCT01430169 · COMPLETED

Trial details

NCT number: NCT01430169
Sponsor: Endo USA Inc., a Keenova Therapeutics Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Peyronie's Disease

Start date: 2011-09-01
Primary completion: 2011-11-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.